Problem of costly drugs "new and enormous" in The Netherlands

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.522, 2007-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Volume and market share of anti-epileptic drugs in the Netherlands: impact of new drugs

By Knoester Pieter   Deckers Charles   Vaart Ronald   Leufkens Bert   Hekster Yechiel  

Pharmacy World and Science, Vol. 27, Iss. 2, 2005-04 ,pp. : 129-134

Springer Publishing Company

Access to resources Recommend Favorite

Drugs stored at home by elderly costly, wasteful

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 415, 2003-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Inappropriate therapy for MRSA costly, potentially deadly, problem

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 561, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Physicians in Canada may be prescribing older, less costly generic drugs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 368, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Physicians in Canada may be prescribing older, less costly generic drugs

By  

Inpharma, Vol. 1, Iss. 1343, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite